The Emtricitabine and Tenofovir Tabl, cataloged under National Stock Number 6505-01-618-5356, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Avkare Llc. Government technical data includes 1 specification, cited from the U.S. Government catalog. The record lists 4 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-618-5356 |
| Primary Part Number | NDC42291-0439-30 |
| Item Name | Emtricitabine and Tenofovir Tabl |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Avkare Llc |
| Status | ACTIVE |
| Protective Storage Feature | CONTROLLED ROOM TEMPERATURE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC42291-0439-30 PRIMARY | Avkare Llc (USA) |
| NDC51407-0112-30 PRIMARY | Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc (USA) |
| NDC00093-7704-56 PRIMARY | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC61958-0701-01 PRIMARY | Gilead Sciences Inc (USA) |
| Reference | Meaning |
|---|---|
| 6505NCM139136 | 5/1 Secondary reference Defense Medical Standardization Board |
| 449511 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-618-5356 is a Emtricitabine and Tenofovir Tabl, manufactured by Avkare Llc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-618-5356 has 4 manufacturer part numbers on file: NDC42291-0439-30 (Avkare Llc), NDC51407-0112-30 (Golden State Medical Supply, Inc. Dba Golden State Medical Supply Inc), NDC00093-7704-56 (Teva Pharmaceuticals Usa, Inc.), NDC61958-0701-01 (Gilead Sciences Inc).
Key specifications for NDC42291-0439-30: Special Features: 200MG EMTRICITABINE AND 300MG OF TENOFOVIR DISOPROXIL FUMARATE; 30 TABLETS PER BOTTLE; TAKEN ORALLY; COMBINATION OF EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE IS INDICATED IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS (SUCH AS NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS OR PROTEASE INHIBITORS) FOR THE TREATMENT OF HIV-1 INFECTION IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER; ALSO APPROVED FOR USE IN COMBINATION WITH SAFER SEX PRACTICES FOR PRE-EXPOSURE PROPHYLAXIS (PREP), TO REDUCE THE RISK OF SEXUALLY ACQUIRED HIV-1 INFECTION IN ADULTS AT HIGH RISK; Protective Storage Feature: CONTROLLED ROOM TEMPERATURE; Part Name Assigned by Controlling Agency: EMTRICITABINE/TENFOVIR (200MG/300MG) TABS 30S. 1 specification is documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.